Monographie - Metoprolol tartrate

Posledná aktualizácia :
05/12/2025

Metoprolol tartrate

Chemický vzorec

Obchodný názov

Obchodné názvy sú orientačné, a zloženie pomocných látok sa môže líšiť v závislosti od krajiny a výrobcu.

Beloc	Nemecko, Rakúsko, Švajčiarsko, Turecko
Beloken	Španielsko
Betaloc	Austrália, Kanada, Kolumbia, Maďarsko, Poľsko, Veľká Británia
Lopresor	Kanada
Selokeen	Holandsko
Seloken	Belgicko, Brazília, Dánsko, Fínsko, Island, Luxembursko, Nórsko, Švédsko, Taliansko

Odkazy na literatúru : Metoprolol tartrate

	Typ	Publikácia
62	Časopis	Pugh CB, Pabis DJ, Rodriguez C. Visual compatibility of morphine sulfate and meperidine hydrochloride with other injectable drugs during simulated Y-site injection. Am J Hosp Pharm 1991 ; 48: 123-125.
238	Časopis	Belliveau PP, Shea BF, Scavone JM. Stability of metoprolol tartrate in 5% dextrose injection or 0.9% sodium chloride injection. Am J Hosp Pharm 1993 ; 50: 950-952.
240	Časopis	Lam XM, Ward CA, de C du M?e CPR. Stability and activity of alteplase with injectable drugs commonly used in cardiac therapy. Am J Health-Syst Pharm 1995 ; 52: 1904-1909.
921	Časopis	Trissel LA, Gilbert DL, Martinez JF. Incompatibility and compatibility of amphotericin B cholesteryl sulfate complex with selected other drugs during simulated Y-site administration. Hosp Pharm 1998 ; 33: 284-292.
1944	Časopis	Hartman CA, Faria CE, Mago K. Visual compatibility of bivalirudin with selected drugs. Am J Health-Syst Pharm 2004 ; 61: 1774.
1964	Časopis	Hartman CA, Baroletti SA, Churchill WW et al. Visual compatibility of argatroban with selected drugs. Am J Health-Syst Pharm 2002 ; 59: 1784-1785.
2267	Časopis	Kraft MD, Johnson CE, Chung C, Julian F. Stability of metoprolol tartrate injection 1 mg/ml undiluted and 0.5 mg/ml in 0.9% sodium chloride injection and 5% dextrose injection. Am J Health-Syst Pharm 2008 ; 65, 7: 636-638.
2269	Časopis	Chan P, Bishop A, Kupiec TC, Trissel LA, Gole D, Jimidar IM, Vermeersch H. Compatibility of ceftobiprole medocaril with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 2008 ; 65, 16: 1545-1551.
2346	Časopis	Newland A.M, Mauro V.F, Alexander K.S. Physical compatibility of metoprolol tartrate injection with selected cardiovascular agents Am J Health-Syst Pharm 2009 ; 66: 986-987.
3249	Časopis	Singh BM, Dedhiya MG, Dinunzio J, Chan P, Kupiec TC, Trissel LA, Laudano JB. Compatibility of ceftaroline fosamil for injection with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 2011 ; 68: 2163-2169.
3372	Časopis	Hanci V, Ali Kiraz H, Ömür D, Ekin S, Uyan B, Yurtlu B.S. Precipitation in Gallipoli: Sugammadex / Amiodarone & Sugammadex / Dobutamine & Sugammadex / Protamine. Rev Bras Anestesiol 2013 ; 63, 1: 163-166.
3538	Časopis	Gilcher Th, Heeb R M, Krämer I. Physikalisch-chemische Stabilität einer Metoprolol-Injektionslösung 1 mg/ml, 50 ml. Krankenhauspharmazie 2013 ; 11: 524-525.
3644	Laboratórium	Calcium gluconate® - Summary of Product Characteristics Hameln Pharmaceuticals 2010
3838	Laboratórium	Magnesium Sulphate - Summary of Product Characteristics Martindale Pharmaceuticals Ltd 2007
3879	Časopis	Foushee Jaime A, Meredith Pmichaele, Fox Laura M, Grace Edward E. Y-site Physical Compatibility of Beta-blocker Infusions with Intensive Care Unit Admixtures. Int J Pharm Compound 2016 ; 20, 4 : 328-332.
3934	Laboratórium	Eptifibatide (Integrilin®) - Résumé des caractéristiques du produit GlaxoSmithKline Laboratoire 2016
4319	Časopis	Lessard J-J, Caron E, Schérer H, Forest J-M, Leclair G. Compatibility of Y-site Injection of Meropenem Trihydrate With 101 Other Injectable Drugs. Hosp Pharm 2020 ; 55, 5: 332-337.
4433	Časopis	Ghazi I.M, El Nekidy W.S, Sood A, Dulku A, Patel R, Patel K. Y-site Administration of Imipenem/Cilastatin/ Relebactam With Common Intravenous Medications Clin Ther 2020 ; 42, 3: 475-485.
4964	Laboratórium	GLUCONATE DE CALCIUM 10 % B.BRAUN, solution pour perfusion - Résumé des caractéristiques du produit. B BRAUN MELSUNGEN AG 2019
5012	Laboratórium	CHLORURE DE MAGNESIUM 10 POUR CENT (1 g/10 ml) LAVOISIER, solution injectable (I.V.) en ampoule - Résumé des caractéristiques du produit. LABORATOIRES CHAIX ET DU MARAIS 2018

Mentions Légales